Dystonia in Huntington's disease: Prevalence and clinical characteristics

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Movement Disorders

• Publication date

  1999-01-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/1531-8257(199901)14:1<95::AID-MDS1016>3.0.CO;2-8PMID 9918350
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Awareness of involuntary movements in Huntington disease.

  1998cited by this paper
• Tolcapone

  1998cited by this paper
• Cervical dystonia as the initial presentation of Huntington's disease

  1996cited by this paper
• Functional decline in Huntington's disease

  1995cited by this paper
• Huntington's disease in venezuela: 7 years of follow‐up on symptomatic and asymptomatic individuals

  1990cited by this paper
• Neuroleptically induced dystonia in Huntington's disease: a case report.

  1989cited by this paper
• Concept and classification of dystonia.

  1988cited by this paper
• Early diagnosis of herpes simplex encephalitis by MRI

  1987cited by this paper
• PET scan investigations of Huntington's disease: Cerebral metabolic correlates of neurological features and functional decline

  1986cited by this paper
• Huntington's disease in Venezuela

  1986cited by this paper
• The use of incompletely linked markers in genetic counseling: accuracy versus linkage.

  1985cited by this paper
• Validity and reliability of a rating scale for the primary torsion dystonias

  1985cited by this paper
• Assessment of extrapyramidal disorders.

  1981cited by this paper

• Update on the Symptomatic Treatment of Huntington’s Disease: From Pathophysiology to Clinical Practice

  2025cites this paper
• Adult-onset Huntington’s disease with unusual presentation of dopa-responsive lower limb dystonia

  2025cites this paper
• A Practical Guide for Clinical Approach to Patients With Huntington’s Disease in Korea

  2024cites this paper
• Clinical Characterisation of Dystonia in Adult Patients with Huntington’s Disease

  2023influential citation
• Huntington’s disease: clinical features, disease mechanisms, and management

  2020cites this paper
• Identification of genetic factors underpinning phenotypic heterogeneity in Huntington's disease and other neurodegenerative disorders

  2020cites this paper
• Language in Dementia

  2020cites this paper
• Alzheimer’s Dementia

  2020cites this paper
• Thalamostriatal degeneration contributes to dystonia and cholinergic interneuron dysfunction in a mouse model of Huntington’s disease

  2020cites this paper
• Spatiotemporal gait characteristics of Huntington’s disease during dual-task walking

  2020cites this paper
• Parkinson’s Disease Dementia

  2020cites this paper
• Gedunin Degrades Aggregates of Mutant Huntingtin Protein and Intranuclear Inclusions via the Proteasomal Pathway in Neurons and Fibroblasts from Patients with Huntington’s Disease

  2019cites this paper
• Maladaptive striatal plasticity and abnormal reward‐learning in cervical dystonia

  2019cites this paper
• Cause or effect: Altered brain and network activity in cervical dystonia is partially normalized by botulinum toxin treatment

  2019cites this paper
• Efficacy of ethyl-EPA as a treatment for Huntington disease: a systematic review and meta-analysis

  2019cites this paper
• The neurobiological basis for novel experimental therapeutics in dystonia.

  2019cites this paper
• The “Stutter‐Step”: A Peculiar Gait Feature in Advanced Huntington's Disease and Chorea‐Acanthocytosis

  2018cites this paper
• Gait, balance, and falls in Huntington disease.

  2018cites this paper
• Deregulation of RNA Metabolism in Microsatellite Expansion Diseases.

  2018cites this paper
• Cannabinoids for Treatment of Dystonia in Huntington’s Disease

  2018cites this paper
• Dystonia-Predominant Adult-Onset

  2017cites this paper
• Clinical characterization of dystonia in adult patients with Huntington's disease

  2017influential citation
• The role of rehabilitation therapy in Huntington disease.

  2017cites this paper
• A Systematic Review of the Huntington Disease-Like 2 Phenotype

  2017cites this paper
• TAK-063, a Novel Phosphodiesterase 10A Inhibitor, Protects from Striatal Neurodegeneration and Ameliorates Behavioral Deficits in the R6/2 Mouse Model of Huntington’s Disease

  2017cites this paper
• Total Word count : 3470 Running Title : Characterisation of Dystonia in Huntington ’ s Disease

  2017influential citation
• Huntington's Disease Revealed by Familial Cervical Dystonia

  2016cites this paper
• Impact of caspase-6 modulation on Huntington disease phenotypes in the YAC128 mouse model

  2016cites this paper
• Dystonia in Machado-Joseph disease: Clinical profile, therapy and anatomical basis.

  2015cites this paper
• Rhes regulates dopamine D2 receptor transmission in striatal cholinergic interneurons.

  2015cites this paper
• Motor onset and diagnosis in Huntington disease using the diagnostic confidence level

  2015cites this paper
• Motor and behavioral phenotype in conditional mutants with targeted ablation of cortical D1 dopamine receptor-expressing cells.

  2015cites this paper
• Genetic and neuropathological study of primary and secondary dystonic syndromes

  2015cites this paper
• Chapter 75 – Huntington Disease

  2015cites this paper
• A study of what helps people with Huntington’s disease live with their condition

  2015cites this paper
• Risk-taking and pathological gambling behavior in Huntington’s disease

  2014cites this paper
• Differential diagnosis of Huntington's disease: what the clinician should know.

  2014cites this paper
• Striatal parvalbuminergic neurons are lost in Huntington's disease: implications for dystonia

  2013cites this paper
• Management of upper extremity dysfunction in people with Parkinson disease and Huntington disease: facilitating outcomes across the disease lifespan.

  2013cites this paper
• The Prevalence of Juvenile Huntington's Disease: A Review of the Literature and Meta-Analysis

  2012cites this paper
• Physiotherapy clinical guidelines for Huntington's disease SPECIAL REPORT

  2012cites this paper
• Adherence to Use of a Home-Based Exercise DVD in People With Huntington Disease: Participants'

  2012cites this paper
• An exploratory study of mobility-related outcome measures and an exercise intervention in people with Huntington's Disease (HD)

  2012influential citation
• Huntington's disease.

  2012cites this paper
• Physiotherapy clinical guidelines for Huntington’s disease

  2012cites this paper
• Tetrabenazine for the treatment of hyperkinetic movement disorders: a review of the literature.

  2012cites this paper
• Towards a Novel Treatment of Huntington´s Disease

  2011cites this paper
• The functional neuroanatomy of dystonia.

  2011cites this paper
• Convergent mechanisms in etiologically-diverse dystonias

  2011cites this paper
• Huntington's disease - clinical signs, symptoms, presymptomatic diagnosis, and diagnosis.

  2011cites this paper
• Chapter 14 – Huntington disease

  2011cites this paper
• Adherence to Use of a Home-Based Exercise DVD in People With Huntington Disease: Participants' Perspectives

  2011cites this paper
• A Message from the Outgoing Chairperson

  2011cites this paper
• Behavioral Assessment of Genetic Mouse Models of Huntington’s Disease

  2011cites this paper
• Characterization of the CAG 140 Mouse Model of Huntington's Disease and the Effects of rAAV Delivered shRNA and hGFP

  2010cites this paper
• Physiotherapy for Patients with Huntington´s Disease : Effects of a Treatment Program with focus on balance and transitions and the Intercorrelation between Assessment Tools

  2010cites this paper
• Chapter 25 - Clinical Features and Care

  2010cites this paper
• Client and therapist views on exercise programmes for early-mid stage Parkinson's disease and Huntington's disease

  2010cites this paper
• Effects of Assistive Device Use on Lower Limb Kinematics during Gait in Individuals with Huntington's Disease

  2010cites this paper
• Huntington disease

  2010cites this paper
• Huntington disease and other choreas.

  2009cites this paper
• THE MANAGEMENT OF NEURODEGENERATIVE SYMPTOMS IN HUNTINGTON ’ S DISEASE

  2009cites this paper
• Primary Progressive Aphasia

  2008cites this paper
• A systematic review of the treatment studies in Huntington’s disease since 1990

  2007cites this paper
• Huntington's disease: clinical characteristics, pathogenesis and therapies.

  2007cites this paper
• A Primer for Speech-Language Pathologists Managing Clients With Huntington's Disease in a Residential Care Facility

  2007cites this paper
• Progressive central nervous system disorders

  2007cites this paper
• Pharmacological management of Huntington's disease: an evidence-based review.

  2006cites this paper
• Neuroimaging in Dystonia

  2006cites this paper
• Clinical gait analysis in neurology

  2005cites this paper
• Case of maternally transmitted juvenile Huntington's disease with a very large trinucleotide repeat

  2005cites this paper
• Gait Disorders : Evaluation and Management

  2005cites this paper
• Huntington’s Disease

  2005cites this paper
• Reliability of spatiotemporal gait outcome measures in Huntington's disease

  2005cites this paper
• Chorea‐acanthocytosis associated with tourettism

  2004cites this paper
• Mistaken diagnosis of psychogenic gait disorder in a man with status cataplecticus ("Limp Man Syndrome")

  2004cites this paper
• Markedly asymmetrical parkinsonism as a leading feature of adult‐onset Huntington's disease

  2004cites this paper
• Motor Deficits as Biomarkers in Huntington’s Disease: Perspectives for Neuroacanthocytosis Syndromes

  2004cites this paper
• Spinocerebellar ataxia type 2 with levodopa‐responsive parkinsonism culminating in motor neuron disease

  2004cites this paper
• Amphetamine‐induced chorea in attention deficit–hyperactivity disorder

  2004cites this paper
• Long‐term outcome of clozapine use for psychosis in parkinsonian patients

  2004cites this paper
• Unusual forehead tremor in a patient with essential tremor

  2004cites this paper
• A review of the treatment options for Huntington’s disease

  2004cites this paper
• Huntington's disease: present treatments and future therapeutic modalities

  2004influential citation
• Vascular hemichorea/hemiballism and topiramate

  2004cites this paper
• Definition and classification of metatarsalgia

  2003cites this paper
• Huntington's Disease and Sydenham's Chorea

  2003cites this paper
• Physiotherapy for people with movement disorders arising from basal ganglia dysfunction.

  2003cites this paper
• Bruxism in Huntington's disease

  2001cites this paper
• Atuação Fisioterapêutica na Doença de Huntington

  2001cites this paper
• Reply

  2001cites this paper
• Dystonia and parkinsonism.

  2001cites this paper
• [Genetics of dystonia].

  2000cites this paper
• Dystonia-predominant adult-onset Huntington disease: association between motor phenotype and age of onset in adults.

  2000cites this paper
• Bruxism in Huntington's disease

  2000cites this paper
• Arm elevation in Huntington's disease: Dystonia or levitation?

  1999cites this paper